GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Theratechnologies Inc (NAS:THTX) » Definitions » Pre-Tax Income

Theratechnologies (Theratechnologies) Pre-Tax Income : $-17.56 Mil (TTM As of Feb. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Theratechnologies Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Theratechnologies's pretax income for the three months ended in Feb. 2024 was $-4.37 Mil. Its pretax income for the trailing twelve months (TTM) ended in Feb. 2024 was $-17.56 Mil. Theratechnologies's pretax margin was -26.90%.

During the past 13 years, Theratechnologies's highest Pretax Margin was 7.12%. The lowest was -156.13%. And the median was -31.54%.


Theratechnologies Pre-Tax Income Historical Data

The historical data trend for Theratechnologies's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Theratechnologies Pre-Tax Income Chart

Theratechnologies Annual Data
Trend Nov14 Nov15 Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23
Pre-Tax Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only -12.50 -22.65 -31.66 -46.79 -23.54

Theratechnologies Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -10.35 -9.89 -0.62 -2.68 -4.37

Competitive Comparison of Theratechnologies's Pre-Tax Income

For the Biotechnology subindustry, Theratechnologies's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Theratechnologies's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Theratechnologies's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Theratechnologies's Pre-Tax Income falls into.



Theratechnologies Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Theratechnologies's Pretax Income for the fiscal year that ended in Nov. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-10.627+-2.321+-10.361+0.769+-0.996
=-23.54

Theratechnologies's Pretax Income for the quarter that ended in Feb. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-2.246+0.207+-2.648+0.42+-0.104
=-4.37

Pre-Tax Income for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-17.56 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Theratechnologies  (NAS:THTX) Pre-Tax Income Explanation

Theratechnologies's Pretax Margin for the quarter that ended in Feb. 2024 is calculated as

Pretax Margin=Pretax Income/Revenue
=-4.371/16.247
=-26.90%

During the past 13 years, Theratechnologies's highest Pretax Margin was 7.12%. The lowest was -156.13%. And the median was -31.54%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Theratechnologies Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Theratechnologies's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Theratechnologies (Theratechnologies) Business Description

Traded in Other Exchanges
Address
2015, rue Peel, 11e etage, Montreal, QC, CAN, H3A 1T8
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States.